Literature DB >> 4899885

Sulphamethoxazole-trimethoprim therapy in urinary tract infection with reference to its haematological effects.

M E Allison, A C Kennedy, J McGeachie, G A McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4899885     DOI： 10.1177/003693306901401004

Source DB:  PubMed          Journal:  Scott Med J        ISSN： 0036-9330            Impact factor:   0.729


× No keyword cloud information.
  5 in total

1.  The use of co-trimazine and co-trimoxazole in elderly patients with urinary tract infections.

Authors:  S Allgulander; S Holm; C Lundgren
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Megaloblastic anaemia due to trimethoprim-sulphamethoxazole therapy in uraemia.

Authors:  G M Yuill
Journal:  Postgrad Med J       Date:  1973-02       Impact factor: 2.401

3.  Sulphamethoxazole-trimethoprim: the first two years.

Authors:  D S Reeves
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

4.  Toxicity of trimethoprim-sulphamethoxazole in patients with megaloblastic haemopoiesis.

Authors:  I Chanarin; J M England
Journal:  Br Med J       Date:  1972-03-11

5.  Trimethoprim Use prior to Pregnancy and the Risk of Congenital Malformation: A Register-Based Nationwide Cohort Study.

Authors:  Jon Trærup Andersen; Morten Petersen; Espen Jimenez-Solem; Jeppe Nørgaard Rasmussen; Nadia Lyhne Andersen; Shoaib Afzal; Kasper Broedbaek; Brian Rafn Hjelvang; Lars Køber; Christian Torp-Pedersen; Henrik Enghusen Poulsen
Journal:  Obstet Gynecol Int       Date:  2013-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.